Stem cell factor inhibition reduces Th2 inflammation and cellular infiltration in a mouse model of eosinophilic esophagitis.

[1]  A. Bredenoord,et al.  Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis. , 2022, The New England journal of medicine.

[2]  M. Maurer,et al.  Anti‐KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria , 2022, Allergy.

[3]  Toshio Watanabe,et al.  Esophageal mast cells may be associated with the perception of symptoms in patients with eosinophilic esophagitis , 2022, Esophagus.

[4]  S. Pittaluga,et al.  Benralizumab completely depletes gastrointestinal tissue eosinophils and improves symptoms in eosinophilic GI disease. , 2022, The journal of allergy and clinical immunology. In practice.

[5]  N. Barrett,et al.  Single-cell RNA sequencing of mast cells in eosinophilic esophagitis reveals heterogeneity, local proliferation and activation that persists in remission. , 2022, The Journal of allergy and clinical immunology.

[6]  D. Katzka,et al.  Eosinophilic Esophagitis. , 2021, The New England journal of medicine.

[7]  P. Malfertheiner,et al.  A Network Meta-Analysis of Randomized Controlled Trials on the Treatment of Eosinophilic Esophagitis in Adults and Children , 2020, Journal of clinical gastroenterology.

[8]  Nicoleta C. Arva,et al.  Mast Cell Infiltration Is Associated With Persistent Symptoms and Endoscopic Abnormalities Despite Resolution of Eosinophilia in Pediatric Eosinophilic Esophagitis. , 2020, The American journal of gastroenterology.

[9]  G. Yancopoulos,et al.  Efficacy of Dupilumab in a Phase 2 Randomized Trial of Adults With Active Eosinophilic Esophagitis. , 2019, Gastroenterology.

[10]  C. Bebbington,et al.  Siglec-8 antibody reduces eosinophil and mast cell infiltration in a transgenic mouse model of eosinophilic gastroenteritis. , 2019, JCI insight.

[11]  Kelley E. Capocelli,et al.  Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference. , 2018, Gastroenterology.

[12]  Ying Li,et al.  Tranilast prevents renal interstitial fibrosis by blocking mast cell infiltration in a rat model of diabetic kidney disease. , 2018, Molecular medicine reports.

[13]  F. Kirchhoff,et al.  Refined protocols of tamoxifen injection for inducible DNA recombination in mouse astroglia , 2018, Scientific Reports.

[14]  A. Lucendo,et al.  Proton Pump Inhibitor Therapy for Eosinophilic Esophagitis: A Paradigm Shift , 2017, The American Journal of Gastroenterology.

[15]  G. Furuta,et al.  Targeting granulocyte‐macrophage colony‐stimulating factor in epithelial and vascular remodeling in experimental eosinophilic esophagitis , 2017, Allergy.

[16]  E. Dellon,et al.  Pathophysiology of Eosinophilic Esophagitis. , 2017, Gastroenterology.

[17]  N. Ishimura,et al.  Eosinophilic esophagitis versus proton pump inhibitor-responsive esophageal eosinophilia: Transcriptome analysis. , 2017, The Journal of allergy and clinical immunology.

[18]  S. Tayel,et al.  Association of stem cell factor gene expression with severity and atopic state in patients with bronchial asthma , 2017, Respiratory Research.

[19]  M. Vicario,et al.  Dietary treatment modulates mast cell phenotype, density, and activity in adult eosinophilic oesophagitis , 2016, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[20]  A. Bredenoord,et al.  Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis , 2015, Gut.

[21]  Biao Hu,et al.  Mesenchymal deficiency of Notch1 attenuates bleomycin-induced pulmonary fibrosis. , 2015, The American journal of pathology.

[22]  D. Broide,et al.  Group 2 innate lymphocytes (ILC2) are enriched in active eosinophilic esophagitis. , 2015, The Journal of allergy and clinical immunology.

[23]  Christopher F. Martin,et al.  Health-Care Utilization, Costs, and the Burden of Disease Related to Eosinophilic Esophagitis in the United States , 2015, The American Journal of Gastroenterology.

[24]  T. Wight,et al.  Hyaluronan Controls the Deposition of Fibronectin and Collagen and Modulates TGF-β1 Induction of Lung Myofibroblasts. , 2015, Matrix biology : journal of the International Society for Matrix Biology.

[25]  T. Korfhagen,et al.  Allergen-induced resistin-like molecule-α promotes esophageal epithelial cell hyperplasia in eosinophilic esophagitis. , 2014, American journal of physiology. Gastrointestinal and liver physiology.

[26]  D. Broide,et al.  Smad3-Deficient Mice Have Reduced Esophageal Fibrosis and Angiogenesis in a Model of Egg-Induced Eosinophilic Esophagitis , 2014, Journal of pediatric gastroenterology and nutrition.

[27]  J. Woosley,et al.  A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease. , 2014, Gastrointestinal endoscopy.

[28]  A. Bredenoord,et al.  Birch pollen sensitization with cross‐reactivity to food allergens predominates in adults with eosinophilic esophagitis , 2013, Allergy.

[29]  R. Niranjan,et al.  Pathogenic role of mast cells in experimental eosinophilic esophagitis. , 2013, American journal of physiology. Gastrointestinal and liver physiology.

[30]  D. Broide,et al.  Anti-IL-5 therapy reduces mast cell and IL-9 cell numbers in pediatric patients with eosinophilic esophagitis. , 2013, The Journal of allergy and clinical immunology.

[31]  Zhe Wu,et al.  Essential role of stem cell factor–c‐Kit signalling pathway in bleomycin‐induced pulmonary fibrosis , 2013, The Journal of pathology.

[32]  K. Preissner,et al.  Mast cells and fibroblasts work in concert to aggravate pulmonary fibrosis: role of transmembrane SCF and the PAR-2/PKC-α/Raf-1/p44/42 signaling pathway. , 2013, The American journal of pathology.

[33]  J. Richter,et al.  Eosinophilic Esophagitis in Adults: an Update on Medical Management , 2013, Current Gastroenterology Reports.

[34]  Kelley E. Capocelli,et al.  Local hypersensitivity reaction in transgenic mice with squamous epithelial IL-5 overexpression provides a novel model of eosinophilic oesophagitis , 2012, Gut.

[35]  M. Moffitt,et al.  Significance of para-esophageal lymph nodes in food or aeroallergen-induced iNKT cell-mediated experimental eosinophilic esophagitis. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[36]  James B. Young,et al.  Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial. , 2012, The Journal of allergy and clinical immunology.

[37]  H. Ortega,et al.  An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis. , 2011, Gastroenterology.

[38]  A. Varki,et al.  Siglec-F Inhibition Reduces Esophageal Eosinophilia and Angiogenesis in a Mouse Model of Eosinophilic Esophagitis , 2011, Journal of pediatric gastroenterology and nutrition.

[39]  C. Wennerås,et al.  Distinctive Blood Eosinophilic Phenotypes and Cytokine Patterns in Eosinophilic Esophagitis, Inflammatory Bowel Disease and Airway Allergy , 2011, Journal of Innate Immunity.

[40]  K. Stringer,et al.  Involvement of mast cells in eosinophilic esophagitis. , 2010, The Journal of allergy and clinical immunology.

[41]  M. Kumarasinghe,et al.  More than just counting eosinophils: proximal oesophageal involvement and subepithelial sclerosis are major diagnostic criteria for eosinophilic oesophagitis , 2010, Journal of Clinical Pathology.

[42]  A. McKenzie,et al.  Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity , 2010, Nature.

[43]  Tsutomu Takeuchi,et al.  Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells , 2009, Nature.

[44]  N. Lukacs,et al.  Pulmonary IL-17E (IL-25) Production and IL-17RB+ Myeloid Cell-Derived Th2 Cytokine Production Are Dependent upon Stem Cell Factor-Induced Responses during Chronic Allergic Pulmonary Disease1 , 2009, The Journal of Immunology.

[45]  C. Beglinger,et al.  Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial , 2009, Gut.

[46]  A. Cerulli,et al.  The cumulative burden of oral corticosteroid side effects and the economic implications of steroid use. , 2009, Respiratory medicine.

[47]  M. Kowalski,et al.  Stem cell factor and its soluble receptor (c-kit) in serum of asthmatic patients- correlation with disease severity , 2009, BMC Pulmonary Medicine.

[48]  S. Aceves,et al.  Relationships between eosinophilic inflammation, tissue remodeling, and fibrosis in eosinophilic esophagitis. , 2009, Immunology and allergy clinics of North America.

[49]  A. Mishra.  Mechanism of eosinophilic esophagitis. , 2009, Immunology and allergy clinics of North America.

[50]  M. Collins,et al.  Interplay of Adaptive Th2 Immunity with Eotaxin-3/C-C Chemokine Receptor 3 in Eosinophilic Esophagitis , 2007, Journal of pediatric gastroenterology and nutrition.

[51]  M. Rothenberg,et al.  Critical role for adaptive T cell immunity in experimental eosinophilic esophagitis in mice , 2007 .

[52]  T. Sentongo,et al.  Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[53]  C. Hogaboam,et al.  Inhibition of SCF attenuates peribronchial remodeling in chronic cockroach allergen-induced asthma , 2006, Laboratory Investigation.

[54]  T. Kondratyuk,et al.  Cytokine Expression in Normal and Inflamed Esophageal Mucosa: A Study into the Pathogenesis of Allergic Eosinophilic Esophagitis , 2006, Journal of pediatric gastroenterology and nutrition.

[55]  R. Olivenstein,et al.  The expression of stem cell factor and c‐kit receptor in human asthmatic airways , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[56]  P. Lincoln,et al.  Inhibition of stem cell factor reduces pulmonary cytokine levels during allergic airway responses , 2004, Clinical and experimental immunology.

[57]  D. Taub,et al.  Stem cell factor induces eosinophil activation and degranulation: mediator release and gene array analysis. , 2002, Blood.

[58]  C. Denton,et al.  Ligand-dependent genetic recombination in fibroblasts : a potentially powerful technique for investigating gene function in fibrosis. , 2002, The American journal of pathology.

[59]  P. Putnam,et al.  The spectrum of pediatric eosinophilic esophagitis beyond infancy: a clinical series of 30 children , 2000, American Journal of Gastroenterology.

[60]  C. Hogaboam,et al.  Stem cell factor-induced airway hyperreactivity in allergic and normal mice. , 1999, The American journal of pathology.

[61]  E. Ruchelli,et al.  Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids. , 1998, Journal of pediatric gastroenterology and nutrition.

[62]  M. Heidtman,et al.  Human Peripheral Blood Eosinophils Express a Functional c-kit Receptor for Stem Cell Factor that Stimulates Very Late Antigen 4 (VLA-4)–mediated Cell Adhesion to Fibronectin and Vascular Cell Adhesion Molecule 1 (VCAM-1) , 1997, The Journal of experimental medicine.

[63]  D. Friend,et al.  Mast cells that reside at different locations in the jejunum of mice infected with Trichinella spiralis exhibit sequential changes in their granule ultrastructure and chymase phenotype , 1996, The Journal of cell biology.

[64]  P. Howarth,et al.  CYTOKINE PRODUCTION BY CELL CULTURES FROM BRONCHIAL SUBEPITHELIAL MYOFIBROBLASTS , 1996, The Journal of pathology.

[65]  J. Caldwell,et al.  Idiopathic eosinophilic esophagitis. , 1993, Radiology.

[66]  A. Bernstein,et al.  Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice--evidence for an impaired c-kit kinase in mutant mice. , 1989, Genes & development.

[67]  Lisa J. Martin,et al.  Identification of ANO1 as a key driver of esophageal epithelial proliferation in eosinophilic esophagitis. , 2019, The Journal of allergy and clinical immunology.

[68]  J. Woosley,et al.  Association Between Body Mass Index and Clinical and Endoscopic Features of Eosinophilic Esophagitis , 2016, Digestive Diseases and Sciences.

[69]  É. Drouin,et al.  High rate of failure to thrive in a pediatric cohort with eosinophilic esophagitis. , 2016, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[70]  D. Broide,et al.  Esophageal remodeling in pediatric eosinophilic esophagitis. , 2007, The Journal of allergy and clinical immunology.

[71]  A. Straumann,et al.  Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response. , 2001, The Journal of allergy and clinical immunology.

[72]  S. Robinson,et al.  Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient. , 1991, Drug metabolism and disposition: the biological fate of chemicals.